A detailed history of Green Alpha Advisors, LLC transactions in Personalis, Inc. stock. As of the latest transaction made, Green Alpha Advisors, LLC holds 118,953 shares of PSNL stock, worth $139,175. This represents 0.13% of its overall portfolio holdings.

Number of Shares
118,953
Previous 119,305 0.3%
Holding current value
$139,175
Previous $250,000 29.2%
% of portfolio
0.13%
Previous 0.18%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 09, 2024

SELL
$1.15 - $2.19 $404 - $770
-352 Reduced 0.3%
118,953 $177,000
Q4 2023

Jan 04, 2024

SELL
$0.93 - $2.35 $7,308 - $18,468
-7,859 Reduced 6.18%
119,305 $250,000
Q3 2023

Oct 10, 2023

BUY
$1.19 - $2.36 $91,933 - $182,321
77,255 Added 154.79%
127,164 $153,000
Q2 2023

Jul 06, 2023

SELL
$1.8 - $3.19 $37,110 - $65,768
-20,617 Reduced 29.23%
49,909 $93,000
Q1 2023

Apr 06, 2023

BUY
$2.01 - $4.17 $7,859 - $16,304
3,910 Added 5.87%
70,526 $194,000
Q4 2022

Jan 12, 2023

BUY
$1.78 - $2.87 $1,739 - $2,803
977 Added 1.49%
66,616 $0
Q3 2022

Oct 14, 2022

SELL
$3.04 - $5.32 $101,776 - $178,108
-33,479 Reduced 33.78%
65,639 $195,000
Q2 2022

Jul 08, 2022

BUY
$3.27 - $8.76 $212,788 - $570,039
65,073 Added 191.14%
99,118 $342,000
Q1 2022

Apr 19, 2022

BUY
$7.56 - $14.3 $28,652 - $54,197
3,790 Added 12.53%
34,045 $279,000
Q4 2021

Jan 12, 2022

BUY
$12.24 - $21.25 $51,028 - $88,591
4,169 Added 15.98%
30,255 $432,000
Q3 2021

Oct 12, 2021

BUY
$16.69 - $26.05 $42,542 - $66,401
2,549 Added 10.83%
26,086 $502,000
Q2 2021

Jul 22, 2021

BUY
$18.15 - $27.75 $427,196 - $653,151
23,537 New
23,537 $595,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $53.7M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Green Alpha Advisors, LLC Portfolio

Follow Green Alpha Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Green Alpha Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Green Alpha Advisors, LLC with notifications on news.